Professional Study Report on Global Internet of Medical Things (IoMT) Market is Expected to Witness
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Global Internet-of-Medical-Things (IoMT) Market Growth at a Rate of 24 60% in the Forecast Period of
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global home healthcare market is projected to reach $214.98 billion by 2025
The market for home healthcare has grown significantly over the years. Furthermore, the development of connected medical devices and software has propelled the growth of the field. Moreover, the COVID-19 pandemic has played a key role in changing the perception of home healthcare, especially in emerging economies such as India.
The study indicates that the global home healthcare market has witnessed significant growth in the past few decades, owing to adoption of mhealth technology. Furthermore, advancement in wearable technology for monitoring of novel vital signs; rise of the Internet of Medical Things (IoMT); evolution of remote monitoring solutions for the treatment of patients in an economical and efficient way; and the launch of products for wide range of applications are some of the prominent factors expected to propel th
Share this article
SAN FRANCISCO, March 11, 2021 /PRNewswire/
Qardio, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted the company 510k clearance for its QardioCore ambulatory ECG device. QardioCore will initially be marketed for holter monitoring applications, for use with QardioMD, Qardio s cloud-based remote patient monitoring solution.
QardioCore extends Qardio s remote patient monitoring platform from primary care and hypertension monitoring to acute care and cardiology, in a single, intuitive platform.
The QardioCore ambulatory ECG from Qardio
QardioCore extends Qardio s RPM platform from primary care and hypertension to acute care and cardiology
QardioCore requires no special skin preparation, gels, adhesives, or patches. It can easily be self-fit, removed, and re-fit by the patient. Ideal for remote deployment, QardioCore does not require an in-clinic fitting. Qardio intends to launch the service in the U.S. in mid-2021.